- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- Monthly Spotlight
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
- Mental Health Month
Virtual Event – Agitation Associated With Alzheimer’s Dementia: Pathophysiology
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Agitation Associated With Alzheimer’s Dementia: Pathophysiology
This is a Virtual Event for PsychU members in DC, Maryland and Virginia.
Tau pathology and neurodegeneration in key prefrontal and subcortical brain regions may increase the risk of developing agitation in Alzheimer’s dementia.1 Specifically, agitation in Alzheimer’s dementia may reflect an imbalance between top-down executive control (i.e., hypoactivity in prefrontal regions) and bottom-up emotional drive (i.e., hyperactivity in subcortical regions including the amygdala).1 Moreover, agitation in Alzheimer’s dementia is associated with noradrenergic, serotonergic, and dopaminergic system dysfunction in brain circuits mediating the balance between executive control and emotional drive.2,3 In this presentation, the speakers will review the loss of behavior regulation and the role of the monoamine system in the pathophysiology of agitation associated with Alzheimer’s Dementia.
References:
1. Rosenberg, P.B., et al. Mol Aspects Med. 2015; 43-44: 25-37.
2. Jacobs, H.I., et al. Mol Psychiatry. 2021; 26(3): 897-906.
3. Lanctôt, K.L., et al. J Neuropsychiatry Clin Neurosci. 2001; 13(1): 5-21.Featuring
Dennis Sholler, PhD (OPDC)
Clinical & Scientific Liaison
Justin Wimmer, PharmD (OPDC)
Clinical & Scientific Liaison
Speakers Dennis Sholler, PhD and Justin Wimmer, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Registration
Related Resources
-
Working With People In Crisis For First Responders
Downloadable Resource May 18, 2023Download Infographic
-
Agitation Associated With Alzheimer’s Dementia: Mechanism Of Disease
Video May 16, 2023Research has shown that in patients with Alzheimer’s dementia, agitation is associated with tau pathology and neurodegeneration in the prefrontal cortex and amygdala regions of the brain.
-
Hot Topics: Clinical Questions in Schizophrenia – Question III
Interview May 15, 2023Dr. Christoph U. Correll will address current and relevant clinical questions relating to schizophrenia. These questions and Dr. Correll’s response will be recorded and released as short videos. When…
Join today for instant access to all PsychU content, events, and more!
Membership is free!
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: